| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.23 | 7e-10 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-07 |